AKTX
Akari TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
AKTX vs peer average
24/100
AKTX vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 2 · D 1 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CMMB is the first available peer comparator.
Chemomab is a similarly micro-cap biotech, but it is not a close mechanism peer; it is useful mainly as a financing-risk and event-volatility reference rather than a read-through on ADC execution.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AKTX
Akari Therapeutics
CMMB
Chemomab Therapeutics
Grade
F
A
Momentum
40
84
Value
42
41
Sentiment
26
63
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs CMMB
AKTX / CMMB
Grade Position
Below peers
AKTX vs. peer average (F vs. C)
24/100
Momentum
40
CMMBValue
42
AKTXSentiment
26
CMMBRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AKTX
CMMB is the first peer returned for this comparison set.